Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Active Trials
    1(100%)

    Phase Distribution

    Phase 4
    1
    100%

    Phase Distribution

    0

    Early Stage

    0

    Mid Stage

    1

    Late Stage

    Phase Distribution1 total trials
    Phase 4Post-market surveillance
    1(100.0%)

    Highest Phase Reached

    Phase 4

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 0 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    1

    all time

    Status Distribution
    Active(1)

    Detailed Status

    Recruiting1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    1
    Active
    1
    Success Rate
    N/A
    Most Advanced
    Phase 4

    Trials by Phase

    Phase 41 (100.0%)

    Trials by Status

    recruiting1100%

    Recent Activity

    1 active trials
    Showing 1 of 1
    recruitingphase_4

    Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?

    NCT06676384

    Clinical Trials (1)

    Showing 1 of 1 trials
    NCT06676384Phase 4

    Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy?

    Recruiting

    All 1 trials loaded

    Drug Details

    Intervention Type
    Drug
    Total Trials
    1